Johnson & Johnson vs Natera, Inc.
JNJ vs NTRA — side-by-side comparison from reported financials. JNJ leads 5, NTRA leads 3 of 8 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Natera, Inc.
NTRA · Healthcare
$400.71+2.54%Strained
| Metric | JNJ | NTRA |
|---|---|---|
| Price | $261.79 | $400.71 |
| Market cap | $631B | $57.8B |
| Revenue (TTM) | $97.9B | $2.71B |
| Revenue growth | +5.6% | +41.1% |
| Net margin | 21.5% | -7.1% |
| Free cash flow | $22.2B | $84.2M |
| Net cash (debt) | ($27.8B) | $1.02B |
| 1-year price return | +37.0% | +131.6% |
| P/E | 29.9 | — |
| P/E vs own history (cheap-side %) | 16% | — |
| Dividend yield | 2.00% | — |
| Return on equity | 26% | -12% |
| CV checks passed | 10 of 11 | 4 of 11 |
| Employees | 140,800 | 6,140 |
Full résumé-style profiles: JNJ CV · NTRA CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.